ALBANY, N.Y., Nov. 11, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 19, 2015, at 3:00 p.m. ET. The conference will be held in New York City, NY.
A live audio and/or webcast and subsequent archived replay of AngioDynamics’ presentation may be accessed via the investor relations section of the Company’s website under “Events & Presentations” at http://investors.angiodynamics.com/events.cfm. The replay will be available for 90 days after the event.
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.
AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
Company Contact: AngioDynamics, Inc. Caitlin Stefanik (518) 795-1418 firstname.lastname@example.org Investor Relations Contact: EVC Group, Inc. Chris Dailey (212) 850-6020 email@example.com; Media Contact: EVC Group, Inc. Dave Schemelia (646) 201-5431 firstname.lastname@example.org